Article Versions Notes

Cantero-García N, Flores-Burgess A, Ladrón de Guevara-Miranda D, Serrano A, García-Durán L, Puigcerver A, Fuxe K, Narváez JÁ, Santín LJ, Díaz-Cabiale Z, et al. The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression. Biomedicines. 2022; 10(2):412. https://doi.org/10.3390/biomedicines10020412

Cantero-García, Noelia, Antonio Flores-Burgess, David Ladrón de Guevara-Miranda, Antonia Serrano, Laura García-Durán, Araceli Puigcerver, Kjell Fuxe, José Ángel Narváez, Luis Javier Santín, Zaida Díaz-Cabiale, and et al. 2022. "The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression" Biomedicines 10, no. 2: 412. https://doi.org/10.3390/biomedicines10020412

Cantero-García, N., Flores-Burgess, A., Ladrón de Guevara-Miranda, D., Serrano, A., García-Durán, L., Puigcerver, A., Fuxe, K., Narváez, J. Á., Santín, L. J., Díaz-Cabiale, Z., & Millón, C. (2022). The Combination of Galanin (1–15) and Escitalopram in Rats Suggests a New Strategy for Alcohol Use Disorder Comorbidity with Depression. Biomedicines, 10(2), 412. https://doi.org/10.3390/biomedicines10020412